• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发并验证一种针对乳腺癌女性激素治疗用药行为的可改变影响因素的理论测量方法。

Developing and validating a theoretical measure of modifiable influences on hormonal therapy medication taking behaviour in women with breast cancer.

作者信息

Cahir Caitriona, Dombrowski Stephan U, Kennedy M John, Sharp Linda, Bennett Kathleen

机构信息

a Division of Population Health Sciences , Royal College of Surgeons in Ireland , Dublin , Ireland.

b Division of Psychology , University of Stirling , Stirling , Scotland.

出版信息

Psychol Health. 2017 Oct;32(10):1308-1326. doi: 10.1080/08870446.2017.1296151. Epub 2017 Feb 28.

DOI:10.1080/08870446.2017.1296151
PMID:28276740
Abstract

OBJECTIVE

Taking adjuvant hormonal therapy for 5-10 years is recommended to prevent breast cancer recurrence in those with oestrogen positive disease. Despite proven clinical efficacy many women do not take their hormonal therapy as prescribed. This study reports the development and initial validation of a questionnaire measuring the behavioural determinants of hormonal therapy medication taking behaviour (MTB) based on the theoretical domains framework (TDF).

DESIGN

Women with Stage I-III breast cancer (N = 223) completed the questionnaire based on the TDF. The TDF is an integrative framework consisting of 14 domains of behaviour change determinants to inform intervention design.

MAIN OUTCOME MEASURES

Items were developed from previous research, in-depth patient interviews and consultation with health professionals. Confirmatory factor analysis (CFA) was undertaken to generate the model of best fit.

RESULTS

The final questionnaire consisted of eight domains and CFA produced a reasonable fit (χ(810) = 942, p < .001; RMSEA = .03; CFI = .93 and WRMR = .91) as well as internal consistency (r = .16 to .64). There were adequate levels of discriminant validity for the majority of the domains.

CONCLUSIONS

A TDF-based measure of the behavioural determinants of MTB was developed. Further research is needed to confirm the reliability and validity of this measure.

摘要

目的

对于雌激素受体阳性的乳腺癌患者,推荐进行5至10年的辅助激素治疗以预防癌症复发。尽管激素治疗的临床疗效已得到证实,但许多女性并未按医嘱进行激素治疗。本研究报告了一份基于理论领域框架(TDF)的问卷的开发及初步验证,该问卷用于测量激素治疗服药行为(MTB)的行为决定因素。

设计

I至III期乳腺癌女性患者(N = 223)完成了基于TDF的问卷。TDF是一个综合框架,由14个行为改变决定因素领域组成,为干预设计提供依据。

主要观察指标

条目基于先前研究、深入的患者访谈以及与健康专业人员的咨询而制定。进行验证性因子分析(CFA)以生成最佳拟合模型。

结果

最终问卷包含八个领域,CFA显示拟合度合理(χ(810) = 942,p <.001;RMSEA =.03;CFI =.93;WRMR =.91)且具有内部一致性(r =.16至.64)。大多数领域具有足够的区分效度。

结论

开发了一种基于TDF的MTB行为决定因素测量方法。需要进一步研究以确认该测量方法的可靠性和有效性。

相似文献

1
Developing and validating a theoretical measure of modifiable influences on hormonal therapy medication taking behaviour in women with breast cancer.开发并验证一种针对乳腺癌女性激素治疗用药行为的可改变影响因素的理论测量方法。
Psychol Health. 2017 Oct;32(10):1308-1326. doi: 10.1080/08870446.2017.1296151. Epub 2017 Feb 28.
2
Women's experiences of hormonal therapy for breast cancer: exploring influences on medication-taking behaviour.乳腺癌激素治疗的女性经历:探究对服药行为的影响
Support Care Cancer. 2015 Nov;23(11):3115-30. doi: 10.1007/s00520-015-2685-x. Epub 2015 Mar 7.
3
Can demographic, clinical and treatment-related factors available at hormonal therapy initiation predict non-persistence in women with stage I-III breast cancer?激素治疗开始时可获得的人口统计学、临床和治疗相关因素能否预测I-III期乳腺癌女性患者的治疗不持续性?
Cancer Causes Control. 2017 Mar;28(3):215-225. doi: 10.1007/s10552-017-0851-9. Epub 2017 Feb 16.
4
Understanding Breast Cancer Survivors' Beliefs and Concerns About Adjuvant Hormonal Therapy: Promoting Adherence.了解乳腺癌幸存者对辅助激素治疗的信念和担忧:促进依从性。
J Cancer Educ. 2018 Apr;33(2):436-439. doi: 10.1007/s13187-017-1180-0.
5
Relationships between determinants of adjuvant endocrine therapy adherence in breast cancer.乳腺癌辅助内分泌治疗依从性的决定因素之间的关系。
BMC Womens Health. 2018 Mar 19;18(1):48. doi: 10.1186/s12905-018-0522-3.
6
Medication taking behaviors among breast cancer patients on adjuvant endocrine therapy.接受辅助内分泌治疗的乳腺癌患者的服药行为
Breast. 2015 Oct;24(5):630-6. doi: 10.1016/j.breast.2015.06.010. Epub 2015 Jul 16.
7
Identifying the determinants of adjuvant hormonal therapy medication taking behaviour in women with stages I-III breast cancer: A systematic review and meta-analysis.确定I-III期乳腺癌女性辅助激素治疗用药行为的决定因素:一项系统评价和荟萃分析。
Patient Educ Couns. 2015 May 30. doi: 10.1016/j.pec.2015.05.013.
8
Measuring illness representations in breast cancer survivors (BCS) prescribed tamoxifen: Modification and validation of the Revised Illness Perceptions Questionnaire (IPQ-BCS).测量接受他莫昔芬治疗的乳腺癌幸存者(BCS)的疾病认知:修订版疾病认知问卷(IPQ-BCS)的修改与验证
Psychol Health. 2017 Apr;32(4):439-458. doi: 10.1080/08870446.2016.1275629. Epub 2017 Jan 4.
9
Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study.乳腺癌患者辅助激素治疗的依从性和停药情况:一项基于人群的研究。
Breast Cancer Res Treat. 2012 May;133(1):367-73. doi: 10.1007/s10549-012-1961-4.
10
Factors influencing medication-taking behaviour with adjuvant endocrine therapy in women with breast cancer: A qualitative systematic review.影响乳腺癌女性辅助内分泌治疗服药行为的因素:一项定性系统评价。
J Adv Nurs. 2020 Feb;76(2):445-458. doi: 10.1111/jan.14253. Epub 2019 Nov 13.

引用本文的文献

1
Survivorship care in breast cancer: understanding implementation barriers through the lens of the Theoretical Domains Framework.乳腺癌生存护理:透过理论领域框架的视角理解实施障碍。
JNCI Cancer Spectr. 2024 Jan 4;8(1). doi: 10.1093/jncics/pkad108.
2
Informing interventions to improve uptake of adjuvant endocrine therapy in women with breast cancer: a theoretical-based examination of modifiable influences on non-adherence.针对提高乳腺癌女性接受辅助内分泌治疗依从性的干预措施:对非依从性的可改变影响的基于理论的检查。
Support Care Cancer. 2023 Mar 4;31(3):200. doi: 10.1007/s00520-023-07658-x.
3
Qualitative Interviews to Support Development and Cognitive Debriefing of the Adelphi Adherence Questionnaire (ADAQ©): A Patient-Reported Measure of Medication Adherence Developed for Use in a Range of Diseases, Treatment Modalities, and Countries.
支持阿德尔菲依从性问卷(ADAQ©)开发与认知反馈的定性访谈:一种为多种疾病、治疗方式及国家设计的患者报告的药物依从性测量工具。
Patient Prefer Adherence. 2022 Sep 15;16:2579-2592. doi: 10.2147/PPA.S358046. eCollection 2022.